Clinical trials
Phase 4 Schizophrenia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 4 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 9 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Mental Health Center | 7 |
| Central South University | 6 |
| Capital Medical University | 2 |
| Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2 |
| Xian-Janssen Pharmaceutical Ltd. | 2 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Jiangsu Province Nanjing Brain Hospital | 1 |
| Nathan Kline Institute for Psychiatric Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 30 |
| Cognition Disorders | 2 |
| Disease | 1 |
| Dyslipidemias | 1 |
| Hyperprolactinemia | 1 |
| Metabolic Syndrome | 1 |
| Psychomotor Agitation | 1 |
| Psychotic Disorders | 1 |
| Recurrence | 1 |
| Sexual Dysfunction, Physiological | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.